International expansion -- Initial clinical use of ReCell Go in select European markets established post-CE Mark approval, ...
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Q4 2025 Earnings Call Transcript February 11, 2026 Neurocrine Biosciences, Inc. misses on earnings expectations. Reported EPS is $1.5 EPS, expectations were ...
Unity Software Inc. (NYSE:U) Q4 2025 Earnings Call Transcript February 11, 2026 Unity Software Inc. misses on earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results